
Dr. Hemant S. Murthy is a Consultant and Professor of Medicine at Mayo Clinic Florida. His clinical and research interests including myeloid disorders, stem cell transplantation and cellular immunotherapy. He is a principal investigator of a number of early phase clinical trials focusing on hematopoietic cell transplantation and cellular immunotherapy for lymphoma, leukemia and solid tumor malignancies. He is also involved in the development of a number of transformative oncology practices at Mayo Clinic, including outpatient and at home stem cell transplantation, remote patient monitoring for at home monitoring of patients receiving immunotherapy and cell therapy, and home based cancer care delivery. He is co-chair of the CIBMTR Infection and Immune Reconstitution Committee and on the 2021 BMT CTN State of the Science Infection and Immune Reconstitution Committee. He was selected to the ASTCT Leadership Course for emerging leaders in Stem Cell Transplantation and Cellular Therapy, the American Society of Hematology Advocacy Leadership Institute and the FMA Karl M. Alternburger Physician Leadership Academy. Dr. Murthy is also committed to enhancing quality care for patients. He is the Chair of Quality for Mayo Clinic Florida and Associate Chair of Medicine. He also serves as co-chair of the Mayo Clinic Comprehensive Cancer Center Protocol Review and Monitoring Committee and leads quality efforts for Mayo Clinic Comprehensive Cancer Center Cellular Therapy. He also sits on international committees for quality with the American Society of Transplantation and Cellular Therapy and the Foundation for Accredidation of Cellular Therapies.
Professor
2019 – present
Assistant Professor
2016 – 2019
Medical School
2004 – 2008
Residency
2008 – 2011
Fellowship
2015 – 2016
Fellowship
2012 – 2015
Fellowship
2011 – 2012